📰 Nyse Zyme News
Nyse Zyme News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nyse Zyme. Real-time updates on events, politics, business and more.
February 27, 2024
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $12.71 and last traded at $12.52, with a volume of 90247 shares trading hands. The stock had previously closed at $12.37. Zymeworks Stock Performance The firm has a market […]
February 27, 2024
Zymeworks Inc. (NYSE:ZYME – Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as $12.71 and last traded at $12.52, with a volume of 90247 shares changing hands. The stock had previously closed at $12.37. Zymeworks Stock Performance The firm has a fifty day simple moving average […]
January 10, 2024
Zymeworks Inc. (NYSE:ZYME – Get Free Report) CFO Christopher Astle sold 4,563 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $10.65, for a total transaction of $48,595.95. Following the completion of the sale, the chief financial officer now owns 7,934 […]
January 10, 2024
Zymeworks Inc. (NYSE:ZYME – Get Free Report) insider Paul Andrew Moore sold 2,339 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $11.22, for a total transaction of $26,243.58. Following the completion of the transaction, the insider now directly owns 7,367 […]
January 9, 2024
Zymeworks Inc. (NYSE:ZYME – Get Free Report) CEO Kenneth Galbraith sold 5,706 shares of the company’s stock in a transaction on Monday, January 8th. The stock was sold at an average price of $11.22, for a total value of $64,021.32. Following the transaction, the chief executive officer now directly owns 23,762 shares in the company, […]
January 9, 2024
Zymeworks Inc. (NYSE:ZYME – Get Free Report) insider Paul Andrew Moore sold 2,339 shares of the company’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $11.22, for a total transaction of $26,243.58. Following the completion of the sale, the insider now directly owns 7,367 shares of […]
December 9, 2023
683 Capital Management LLC lowered its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 65.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,900 shares of the company’s stock after selling 125,100 shares during […]
December 9, 2023
683 Capital Management LLC lessened its position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 65.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 64,900 shares of the company’s stock after selling 125,100 shares during the period. […]
November 27, 2023
Zymeworks Inc. (NYSE:ZYME – Get Free Report)’s share price shot up 3.8% on Monday . The company traded as high as $8.47 and last traded at $8.45. 118,028 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 568,921 shares. The stock had previously closed at $8.14. Wall Street […]
November 19, 2023
Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given an average rating of “Hold” by the seven brokerages that are presently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective […]